Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Repeatability of Inhaled ATP Cough Challenges
NCT07085975Phase 1Recruiting
- Sponsor
- McMaster University
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of adenosine 5'-triphosphate, sponsored by McMaster University. Primary endpoints: Mean %FEV1 change from baseline, Symptoms of wheeze measured on the mBorg scale and 9 more. Started Aug 2025; status: recruiting.
02
Drugs
adenosine 5'-triphosphate
Beyond the preview
Go deeper on NCT07085975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07085975.